Alector, Inc. - ALEC Company Short-Term Debt

Graphic logo of alector.com (ALEC)

Alector, Inc. (ALEC) is a biotech developer of Alzheimer's treatments whose growth model relies on the high margins of patented drugs following the completion of clinical trials. Business security is ensured by unique developments in overcoming the blood-brain barrier and strategic alliances with industry leaders. The price trajectory of the asset, where the individual debt indicator is 0.00, clearly demonstrates the market dynamics of this neuromedicine company.

ALEC (Alector, Inc.) Company Short-Term Debts history from 07/04/2022 to 10/28/2026

Summary analytical data breakdowns for Alector Inc. (ALEC)

- price and consensus price forecast:
Price Chart Alector Therapeutics|ALEC - Fair Value Consensus
- market capitalization data:
Market Value Alector, Inc.|ALEC - Total Enterprise Value
- book capitalization data:
Book Value per Share Alector|ALEC - Book Capitalization|Market Value to Book Value Ratio alector.com|ALEC - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Capital Alector, Inc.|ALEC - Long-Term Liabilities to Capital|Short-Term Debt to Capital Alector Therapeutics|ALEC - Company Total Debt|Debt to Book Value Alector, Inc.|ALEC - Amount of Long-Term Liabilities|Company Short-Term Debt Alector
Initial company analysis:ALEC (alector.com)
Finished products of Alector Inc.

Fundamental asset selection requires strict monitoring of liabilities with a maturity of up to one year. This indicator captures the total amount of short-term borrowings, determining the issuer's current solvency and liquidity risk. For Alector, Inc. (ALEC), this metric is critical due to the high capital burn rate associated with R&D research. Rising debt during the waiting period for test results could intensify financial pressure. By analyzing the book value of short-term debt, an investor assesses the company's resilience to cash flow gaps.

Competitor analysis for Alector, Inc.

Company Short-Term Debt Biogen (BIIB)|NBIX: Company Short-Term Loans and Borrowings|Company Short-Term Debt RGC|Axsome Corp (AXSM) - Short-Term Debt|ACAD (ACADIA Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts XENE|Company Short-Term Debt Viking Therapeutics, Inc. (VKTX)|Company Short-Term Debt Supernus Pharmaceuticals, Inc. (SUPN)|CPRX: Company Short-Term Debts|Short-Term Debt Denali Corp DNLI|HRMY: Company Short-Term Debts|biohavenpharma.com (BHVN) - Company Current Liabilities|AMLX - Company Current Liabilities|TRVI (Trevi Therapeutics Inc) - Amount of Current Liabilities|Company Short-Term Debt PRAX (Praxis Medicines)|Short-Term Debt AVXL|CeriBell, Inc. (CBLL) - Company Short-Term Debt|Company Short-Term Loans and Borrowings Prothena Corporation plc PRTA|Company Current Liabilities Annexon|Company Short-Term Loans and Borrowings Omeros Corp OMER|Company Short-Term Debts NGNE (Neurogene Corp)|ACIU: Short-Term Debt Volume|Company Short-Term Debt Voyager Therapeutics|neumoratx.com (NMRA) - Company Short-Term Indebtedness|Company Short-Term Debts SCLX|Company Current Liabilities Tevogen Bio Holdings Inc. (TVGN)|ACOG (Alpha Cognition) - Company Current Liabilities|Short-Term Debt Volume cogrx.com (CGTX)|Company Short-Term Debts IKT (Inhibikase Therapeutics)|cassavasciences.com - Company Short-Term Debts|ASRT - Company Short-Term Debt|COYA - Company Short-Term Debt|Company Short-Term Debts VTGN|Ovid Therapeutics (OVID) - Short-Term Debt|Company Short-Term Debts ABOS|Company Current Liabilities CRVO|Company Short-Term Debt Alterity Therapeutics ATHE|Company Short-Term Indebtedness clene.com (CLNN)|PEPG: Company Short-Term Debts|JUNS - Short-Term Debt|Relmada Therapeutics - Company Current Liabilities|ANVS: Company Short-Term Debts|Company Short-Term Debt gracetx.com GRCE|AIFF (Firefly Neuroscience, Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debt KLTO (ANEW Medical)|Short-Term Debt NeuroSense Therapeutics, Ltd.|Company Short-Term Debts RVPH|Company Short-Term Debts MTVA (metaviatx.com)|Company Short-Term Debt NeurAxis NRXS|Company Short-Term Debt Helius Medical Technologies, Inc. HSDT|PASG (Passage Bio Corp) - Company Short-Term Debts|NEUP - Short-Term Debt|NERV (Minerva Neurosciences) - Company Short-Term Debts|Company Current Liabilities athira.com|Addex Therapeutics Ltd (ADXN) - Company Current Liabilities|Amount of Current Liabilities ALZN|Cyclerion Therapeutics - Company Short-Term Debt|Short-Term Debt PTIX (protagenic.com)|Company Short-Term Debt Pasithea Therapeutics Corp.|CRGT - Company Short-Term Loans and Borrowings|Company Current Liabilities Avenue Therapeutics, Inc. (ATXI)|BCLI - Company Short-Term Loans and Borrowings|Cara Therapeutics, Inc - Company Short-Term Debts|CHRO (Chromocell) - Short-Term Debt Volume|Company Short-Term Debt Eliem Therapeutics, Inc. (ELYM)|Company Short-Term Indebtedness Intra-Cellular|Company Short-Term Debts LBPH (Longboard Pharmaceuticals, Inc.)|Company Current Liabilities Marinus Pharmaceuticals Inc MRNS|Company Current Liabilities NKGN|Short-Term Debt Volume NeuroBo Pharma NRBO|Sage Therapeutics, Inc. - Company Short-Term Debts|SNPX: Company Short-Term Debts|Trevena (TRVN) - Company Short-Term Debt|Vigil Neuroscience, Inc. (VIGL) - Company Short-Term Debt|Company Short-Term Debts WENA (Anew Medical, Inc.)|Short-Term Debt Cerevel Corp